J
Joshua M. Farber
Researcher at National Institutes of Health
Publications - 107
Citations - 14702
Joshua M. Farber is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Chemokine & Chemokine receptor. The author has an hindex of 55, co-authored 99 publications receiving 14016 citations.
Papers
More filters
Journal ArticleDOI
CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease
TL;DR: In this paper, the chemokine receptors CXCR4 and CCR5, members of the G protein-coupled receptor superfamily, have been identified as the principal coreceptors for T cell line-tropic and macrophagetropic HIV-1 isolates, respectively.
Journal ArticleDOI
Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2
Arya Biragyn,Pier Adelchi Ruffini,Cynthia A. Leifer,Elena Klyushnenkova,Alexander Shakhov,Oleg Chertov,Aiko Konno Shirakawa,Joshua M. Farber,David M. Segal,Joost J. Oppenheim,Larry W. Kwak +10 more
TL;DR: It is demonstrated that murine β-defensin 2 (mDF2β) acts directly on immature dendritic cells as an endogenous ligand for Toll-like receptor 4 (TLR-4), inducing up-regulation of costimulatory molecules and d endritic cell maturation, suggesting that mDF2 β may play an important role in immunosurveillance against pathogens and, possibly, self antigens or tumor antigENS.
Journal ArticleDOI
Mig and IP-10: CXC chemokines that target lymphocytes
TL;DR: RHuMig and rIP‐10 share additional activities, including inhibition of neovascularization, inhibition of hematopoietic progenitor cells, and anti‐tumor effects, and that, despite their similar activities assayed in vitro, Mig and IP‐10/Crg‐2 may serve non‐redundant functions in vivo.
Journal ArticleDOI
International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
Françoise Bachelerie,Adit Ben-Baruch,Amanda M. Burkhardt,Christophe Combadière,Joshua M. Farber,Gerard J. Graham,Richard Horuk,Alexander Hovard Sparre-Ulrich,Massimo Locati,Andrew D. Luster,Alberto Mantovani,Kouji Matsushima,Philip M. Murphy,Robert J. B. Nibbs,Hisayuki Nomiyama,Christine Power,Amanda E. I. Proudfoot,Mette M. Rosenkilde,Antal Rot,Silvano Sozzani,Marcus Thelen,Osamu Yoshie,Albert Zlotnik +22 more
TL;DR: This work reviews this extended family of chemokine receptors and Chemokine-binding proteins at the basic, translational, and clinical levels, including an update on drug development and introduces a new nomenclature for atypical chemokin receptors with the stem ACKR (atypicalChemokine receptor).
Human Interferon-inducible Protein 10 Is a Potent Inhibitor of Angiogenesis In Vivo By Anne L. Angiolillo,* Cecilia Sgadari,~ Dennis D. Taub, S
Fang Liao,Joshua M. Farber,Shalu Maheshwari,Hynda K. Kleinman,Gregory H. Keaman,Giovanna Tosato +5 more
TL;DR: In this article, the authors reported that IP-10 is a potent inhibitor of angiogenesis in vivo and showed that it significantly inhibited basic fibroblast growth factor-induced neovascularization of Matrigel.